136 related articles for article (PubMed ID: 15082419)
21. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
[TBL] [Abstract][Full Text] [Related]
23. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y
Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640
[TBL] [Abstract][Full Text] [Related]
24. Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats.
Guo Q; Minami N; Mori N; Nagasaka M; Ito O; Kurosawa H; Kanazawa M; Kohzuki M
Hypertens Res; 2008 Mar; 31(3):525-33. PubMed ID: 18497473
[TBL] [Abstract][Full Text] [Related]
25. Changes in renal vessels following the long-term administration of an angiotensin II receptor blocker in Zucker fatty rats.
Nakanishi K; Nagai Y; Honglan Piao ; Akimoto T; Kato H; Yanakieva-Georgieva N; Ishikawa Y; Yoshihara K; Ito K; Yamanaka N; Oite T
J Renin Angiotensin Aldosterone Syst; 2011 Jun; 12(2):65-74. PubMed ID: 21385769
[TBL] [Abstract][Full Text] [Related]
26. Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats.
Nakamoto T; Harasawa H; Akimoto K; Hirata H; Kaneko H; Kaneko N; Sorimachi K
Eur J Pharmacol; 2005 Dec; 528(1-3):43-51. PubMed ID: 16336959
[TBL] [Abstract][Full Text] [Related]
27. Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.
Rodriguez R; Minas JN; Vazquez-Medina JP; Nakano D; Parkes DG; Nishiyama A; Ortiz RM
J Endocrinol; 2018 Jun; 237(3):271-284. PubMed ID: 29643115
[TBL] [Abstract][Full Text] [Related]
28. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
Pugsley MK
Proc West Pharmacol Soc; 2005; 48():35-8. PubMed ID: 16416656
[TBL] [Abstract][Full Text] [Related]
29. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
[TBL] [Abstract][Full Text] [Related]
30. Insulin-regulated Srebp-1c and Pck1 mRNA expression in primary hepatocytes from zucker fatty but not lean rats is affected by feeding conditions.
Zhang Y; Chen W; Li R; Li Y; Ge Y; Chen G
PLoS One; 2011; 6(6):e21342. PubMed ID: 21731709
[TBL] [Abstract][Full Text] [Related]
31. [A novel synthesis of olmesartan medoxomil and examination of its related impurities].
Wu TZ; Liu XH; Zhang FL; Xie MH
Yao Xue Xue Bao; 2006 Jun; 41(6):537-43. PubMed ID: 16927829
[TBL] [Abstract][Full Text] [Related]
32. Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein.
Namikoshi T; Tomita N; Satoh M; Haruna Y; Kobayashi S; Komai N; Sasaki T; Kashihara N
Am J Hypertens; 2007 Oct; 20(10):1085-91. PubMed ID: 17903692
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
Chen M; Ichiki T; Ohtsubo H; Imayama I; Inanaga K; Miyazaki R; Sunagawa K
Hypertens Res; 2007 Oct; 30(10):971-8. PubMed ID: 18049030
[TBL] [Abstract][Full Text] [Related]
34. Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle.
Yamaguchi K; Ura N; Murakami H; Togashi N; Hyakukoku M; Higashiura K; Shimamoto K
Hypertens Res; 2005 Sep; 28(9):773-8. PubMed ID: 16419651
[TBL] [Abstract][Full Text] [Related]
35. Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
Shimizu S; Saito M; Oiwa H; Ohmasa F; Tsounapi P; Oikawa R; Dimitriadis F; Martin DT; Satoh I; Kinoshita Y; Tomita S
Neurourol Urodyn; 2014 Mar; 33(3):350-7. PubMed ID: 23775684
[TBL] [Abstract][Full Text] [Related]
36. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
[TBL] [Abstract][Full Text] [Related]
37. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Hasler C; Nussberger J; Maillard M; Forclaz A; Brunner HR; Burnier M
Clin Pharmacol Ther; 2005 Nov; 78(5):501-7. PubMed ID: 16321616
[TBL] [Abstract][Full Text] [Related]
38. An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats.
Oyama N; Yagita Y; Sasaki T; Omura-Matsuoka E; Terasaki Y; Sugiyama Y; Sakoda S; Kitagawa K
J Neurosci Res; 2010 Oct; 88(13):2889-98. PubMed ID: 20544833
[TBL] [Abstract][Full Text] [Related]
39. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.
Kurikawa N; Suga M; Kuroda S; Yamada K; Ishikawa H
Br J Pharmacol; 2003 Jul; 139(6):1085-94. PubMed ID: 12871826
[TBL] [Abstract][Full Text] [Related]
40. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia.
Sturzeneker MC; Ioshii SO; Villela Baroncini LA; Précoma DB
Atherosclerosis; 2011 May; 216(1):97-102. PubMed ID: 21338989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
